Back
Prelude Therapeutics Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
1
PRLD
Prelude Therapeutics
Last Price:
2.57
Seasonality Move:
-34.13%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Prelude Therapeutics Price Quote
$2.57
+0.13 (+5.33%)
(Updated: September 19, 2024 at 3:25 PM ET)
Prelude Therapeutics Key Stats
Sell
1
Prelude Therapeutics (PRLD)
is a Sell
Day range:
$2.41 - $2.55
52-week range:
$1.66 - $6.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.74%
Volume:
442.4K
Avg. volume:
358.1K
1-year change:
-23.03%
Market cap:
$134.3M
Revenue:
$0
EPS:
$-1.8
How Much Does Prelude Therapeutics Make?
Data Unavailable
Is Prelude Therapeutics Growing As A Company?
Data Unavailable
Prelude Therapeutics Stock Price Performance
-
Did Prelude Therapeutics Stock Go Up Last Month?
Prelude Therapeutics share price went down by -53.17% last month -
Did PRLD's Share Price Rise Over The Last Year?
PRLD share price fell by -23.03% over the past 1 year
What Is Prelude Therapeutics 52-Week High & Low?
-
What Is Prelude Therapeutics’s 52-Week High Share Price?
Prelude Therapeutics has traded as high as $6.80 over the past 52 weeks -
What Is Prelude Therapeutics’s 52-Week Low Share Price?
Prelude Therapeutics has traded as low as $1.66 over the past 52 weeks
Prelude Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Prelude Therapeutics?
-
How Much Debt Does Prelude Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Prelude Therapeutics Have?
Cash and short term investments quarterly total is $179.8M -
What Is Prelude Therapeutics’s Book Value Per Share?
Book value per share is 3.31
Is Prelude Therapeutics Cash Flow Positive?
-
What Is PRLD Cash Flow From Operations?
Cash flow from operations (TTM) is -$104.1M -
What Is Prelude Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.4M -
What Is Prelude Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $80.1M
Prelude Therapeutics Return On Invested Capital
Data Unavailable
Prelude Therapeutics Earnings Date & Stock Price
-
What Is Prelude Therapeutics's Stock Price Today?
A single share of PRLD can be purchased today for 2.44 -
What Is Prelude Therapeutics’s Stock Symbol?
Prelude Therapeutics trades on the nasdaq under the ticker symbol: PRLD -
When Is Prelude Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Prelude Therapeutics is scheduled on November 1, 2024 -
When Is PRLD's next ex-dividend date?
Prelude Therapeutics's next ex-dividend date is September 19, 2024 -
How To Buy Prelude Therapeutics Stock?
You can buy Prelude Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Prelude Therapeutics Competitors
-
Who Are Prelude Therapeutics's Competitors?
Below is a list of companies who compete with Prelude Therapeutics or are related in some way:
Prelude Therapeutics Dividend Yield
-
What Is PRLD Dividend Yield?
Prelude Therapeutics’s dividend yield currently is 0% -
What Is Prelude Therapeutics’s Payout Ratio?
Prelude Therapeutics’s payout ratio is 0% -
When Did Prelude Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Prelude Therapeutics’s Dividend Per Share?
Prelude Therapeutics pays a dividend of $0.00 per share
Prelude Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -7.6% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 1 |
| Price Target: | 5.80 |
| Upside from Last Price: | 137.7% |